Pathobiology of Hepatic Epithelia: Prospective Tissue Collection

Overview

About this study

This research study will help us to improve our understanding of normal liver and gallbladder function and liver and gallbladder diseases including PBC, PSC, ADPKD (Autosomal Dominant Polycystic Kidney Disease), and ARPKD (Autosomal Recessive Polycystic Kidney Disease) and gallbladder inflammation (cholecystitis).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Potential surgical candidate to treat primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), ADPKD (Autosomal Dominant Polycystic Kidney Disease), ARPKD (Autosomal Recessive Polycystic Kidney Disease), liver resection or gallbladder disease.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nicholas LaRusso, M.D.

Open for enrollment

Contact information:

M Felmlee Devine M.S., CCRP

(507)284-6649

FelmleeDevine.Donna@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20318063

Mayo Clinic Footer